This topic contains a solution. Click here to go to the answer

Author Question: In the early 1800s, it became clear that the standardization of drug purity and strength was ... (Read 15 times)

laurencescou

  • Hero Member
  • *****
  • Posts: 593
In the early 1800s, it became clear that the standardization of drug purity and strength was necessary. Which reasons reflected this need?
 
  1. Strength and purity of products varied from region to region and batch to batch.
  2. Strength and purity of products depended on the pharmacist's experience.
  3. Strength and purity of products would vary in size, taste, and nutritional value.
  4. Strength and purity were mostly guaranteed if products were produced locally, which caused a hardship for those outside the region.
  5. Strength and purity could be trusted when the product had gone through extensive local testing.

Question 2

The Pure Food and Drug Act (PFDA) of 1906 was significant in that it gave the government the power to prohibit drug labels from claiming false therapeutic benefits.
 
  However, there were still several weaknesses in the legislature of this act. Which statements most accurately describe these weaknesses?
  1. This law did not require drug manufacturers to prove that the drug was effective in its claims.
  2. This law did not prevent drugs from being marketed for any disease.
  3. This law required all drug labels to accurately describe their contents.
  4. This law required adequate testing for safety prior to marketing.
  5. This law did not encourage the development of drugs for rare or unusual disorders.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

dudman123

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

Correct Answer: 1,2,3
Rationale 1: The strength and purity of the products varied considerably because they were dependent on the experience of the pharmacist and the quality of the local ingredients, which could vary from region to region and batch to batch.
Rationale 2: The strength and purity of the products varied considerably because they were dependent on the experience of the pharmacist and the quality of the local ingredients, which could vary from region to region and batch to batch.
Rationale 3: The strength and purity of the products varied considerably because they were dependent on the experience of the pharmacist and the quality of the local ingredients, which could vary from region to region and batch to batch.
Rationale 4: Strength and purity could not be guaranteed, even if produced locally. Causing a hardship on those outside the region had nothing to do with determining that standardization was needed.
Rationale 5: Extensive testing prior to marketing did not occur until the early 1930s.
Global Rationale: The strength and purity of the products varied considerably because they were dependent on the experience of the pharmacist and the quality of the local ingredients, which could vary from region to region and batch to batch. Because of this, standardization was necessary. Strength and purity could not be guaranteed, even if produced locally. Causing a hardship on those outside the region had nothing to do with determining that standardization was needed. Extensive testing prior to marketing did not occur until the early 1930s.

Answer to Question 2

Correct Answer: 1,2
Rationale 1: The fact that manufacturers did not have to prove efficacy was a tremendous weakness in the regulation of drugs in the early 20th century.
Rationale 2: The PFDA of 1906 did not address false therapeutic claims.
Rationale 3: Requiring drug labels to identify their contents is not a weakness of the PFDA.
Rationale 4: The PFDA did not require testing for safety prior to marketing. It was not until Congress passed the Food, Drug, and Cosmetic Act that drugs had to be tested for safety prior to marketing.
Rationale 5: The act that encouraged the research and development of drugs for rare or unusual disorders is called the Orphan Act.
Global Rationale: The weaknesses of the PFDA of 1906 include the fact that manufacturers did not have to prove efficacy in the regulation of drugs in the early 20th century and the Act did not address false therapeutic claims. Requiring drug labels to identify their contents is not a weakness of the PFDA. The PFDA did not require testing for safety prior to marketing. It was not until Congress passed the Food, Drug, and Cosmetic Act that drugs had to be tested for safety prior to marketing. The act that encouraged the research and development of drugs for rare or unusual disorders is called the Orphan Act.




laurencescou

  • Member
  • Posts: 593
Reply 2 on: Jul 23, 2018
:D TYSM


nanny

  • Member
  • Posts: 313
Reply 3 on: Yesterday
Excellent

 

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

Asthma attacks and symptoms usually get started by specific triggers (such as viruses, allergies, gases, and air particles). You should talk to your doctor about these triggers and find ways to avoid or get rid of them.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Vampire bats have a natural anticoagulant in their saliva that permits continuous bleeding after they painlessly open a wound with their incisors. This capillary blood does not cause any significant blood loss to their victims.

Did you know?

Approximately 70% of expectant mothers report experiencing some symptoms of morning sickness during the first trimester of pregnancy.

For a complete list of videos, visit our video library